tiprankstipranks
Polarean Enhances UVA Health’s MRI Capabilities
Company Announcements

Polarean Enhances UVA Health’s MRI Capabilities

Polarean Imaging (GB:POLX) has released an update.

Pick the best stocks and maximize your portfolio:

Polarean Imaging PLC has announced a trade-in agreement with the University of Virginia Health System to upgrade their MRI facilities with two new clinical-grade hyperpolariser systems, enhancing their research and clinical capabilities in lung disease imaging. The company expects to install the new systems later this year and aims to expand the use of their FDA-approved XENOVIEW™ technology, which provides a non-invasive and radiation-free way to assess lung function. CEO Christopher von Jako expressed enthusiasm for the upgrade, noting it as a significant step in Polarean’s strategy to transition research centers to clinical-grade operations.

For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskAmati Global Investors Reduces Stake in Polarean Imaging
TheFlyPolarean Imaging announces FDA clearance of XENOVIEW 3T chest coil
TipRanks UK Auto-Generated NewsdeskPolarean Imaging Expands FDA Clearance for MRI Technology
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App